Results 271 to 280 of about 2,398,808 (296)

A Novel Antibody-Drug Conjugate Targeting Nectin-2 Suppresses Ovarian Cancer Progression in Mouse Xenograft Models

International Journal of Molecular Sciences, 2022
Min-Duk Seo, Sang Gyu Park
exaly  

Antibody-drug conjugate

2014
MASUDA TAKESHI, NAITO HIROYUKI, NAKADA TAKASHI, YOSHIDA MASAO, ASHIDA SHINJI, MIYAZAKI HIDEKI, KASUYA YUJI, MORITA KOJI, ABE YUKI, OGITANI YUSUKE   +9 more
openaire   +14 more sources

Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer

Annals of Oncology, 2016
Yulei Wang, J R Infante, M J Birrer
exaly  

PDL-1 Antibody Drug Conjugate for Selective Chemo-Guided Immune Modulation of Cancer

Cancers, 2019
Hashem Alsaab, Samaresh Sau, Arun Iyer   +2 more
exaly  

Antibody-drug conjugates

2018
LIN NAN-HORNG, TSAI CHARNG-SHENG, HUNG TING-CHUN, CHUANG HONG-YANG   +3 more
openaire   +4 more sources

Lorvotuzumab mertansine: antibody-drug-conjugate for CD56⁺ multiple myeloma

Frontiers in Bioscience - Landmark, 2014
Jesus Berdeja
exaly  

Advances in Antibody–Drug Conjugate Design: Current Clinical Landscape and Future Innovations

SLAS Discovery, 2020
exaly  

Comprehensive preclinical pharmacokinetic evaluations of trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, in cynomolgus monkeys

Xenobiotica, 2019
Hideyuki Shiozawa, Osamu Ando
exaly  

Antibody-drug conjugates and methods

2006
EBENS JR ALLEN J, JACOBSON FREDERIC S, POLAKIS PAUL, SCHWALL RALPH H, SLIWKOWSKI MARK X, SPENCER SUSAN D   +5 more
openaire   +11 more sources

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish Shanbhag, Richard Ambinder
exaly